13 WORLD GASTROENTEROLOGY NEWS MAY 2017 Editorial | Expert Point of View | WCOG at ACG 2017 | WDHD News | WGO & WGOF News | WGO Global Guidelines | Calendar of Events World Digestive Health Day in Montenegro: Your Diet in IBD and Liver Diseases Brigita Smolovic, MD, PhD Gastroenterohepatologist Assoc. Prof. Faculty of Medicine, Podgorica Clinical Center of Montenegro The Gastroenterohepatology Associa-tion of Montenegro celebrated World Digestive Health Day 2016, on 25 November. The theme was “Your diet in IBD and liver diseases”. The symposium was held in Podgorica. The event was attended by doctors and pharmacists. They actively participated in the discus-sion. The conference was attended by representatives of the medical journal MEDICAL. A report from the meet-ing with pictures was published in the December issue of the journal. There were two lectures: Dr. Velimir Milosević, PhD (Faculty of Medicine in Podgorica) on “Nutrition in IBD - from the cause to the treatment” and Assoc. Prof. Brigita Smolović Lecture by Dr. Velimir Milosevic Inflammatory bowel diseases (IBD) seem to result from the complex interaction of our genetic makeup, the increasingly clean environment in which we live, the food we eat and the bacterial flora in our gut. Lecture by Dr. Brigita Smolovic Attendees at the WDHD event (Faculty of Medicine in Podgorica) on “Healthy food for a healthy liver.” Diet and IBD Inflammatory bowel diseases (IBD) seem to result from the complex interaction of our genetic makeup, the increasingly clean environment in which we live, the food we eat and the bacterial flora in our gut. The causes of IBD in foods could include some of the following: different culprits such as too many carbohydrates (es-pecially refined); saturated fatty acids; excessive intake of iron and also the lack of glutamine and arginine; lack of fiber in the diet (“low fiber diet”); the absence of production of SCFA; and vitamin D and calcium. Thus dietary therapy may be one of the fundamental components of successful therapy. Nutrition during an acute disease flare differs from that allowed during a symptom-free interval. During the remission phase, however, patients with IBD do not experience lactose intolerance at a rate that is higher than that observed in the general population. If a breath test confirms the diagnosis of lactose intolerance, patients should avoid lactose-containing foods for at least the next three to four weeks. Because most patients tolerate small amounts of lactose, individual testing of tolerance is recommended. During mild inflammatory flares or during
ewgn-vol22-issue1-v11
To see the actual publication please follow the link above